Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the CEA Carcino Embryonic Antigen Body Fluid Test is 7 days.

What are the prerequisites for the test CEA Carcino Embryonic Antigen Body Fluid Test

  • Patient must be at least 18 years old
  • No fasting or special preparation required
  • Patient must inform the healthcare provider about any medications or supplements being taken
  • Patient should avoid smoking or using tobacco products at least 24 hours before the test
  • Patient should not have any recent radiation therapy or chemotherapy

What are the measure values for the test CEA Carcino Embryonic Antigen Body Fluid Test

CEA Carcino Embryonic Antigen Test Body Fluid
Normal Range Less than 5 ng/mL
Borderline Range 5-10 ng/mL
Abnormal Range Above 10 ng/mL

What does this test CEA Carcino Embryonic Antigen Body Fluid Test identify?

The CEA Carcino Embryonic Antigen Body Fluid Test is a diagnostic test that identifies the presence of Carcino Embryonic Antigen (CEA) in body fluids. CEA is a protein that is elevated in certain types of cancer, particularly colorectal cancer. This test is commonly used to monitor the progression of cancer or to detect recurrence after treatment.

Why is this test CEA Carcino Embryonic Antigen Body Fluid Test taken?

  • CEA Carcino Embryonic Antigen Body Fluid Test:
  • The CEA Carcino Embryonic Antigen Body Fluid Test is taken to measure the levels of carcinoembryonic antigen (CEA) in body fluids such as blood, urine, or cerebrospinal fluid. CEA is a protein that is normally produced in very low levels in adults, but elevated levels of CEA can indicate the presence of certain types of cancer, particularly colorectal cancer. This test is often used to monitor the effectiveness of cancer treatment, detect cancer recurrence, or assess the prognosis of cancer patients.

No FAQs available.

Customer Google Rating